Veterinary oncology Market
The global veterinary oncology market is estimated to reach $0.819 billion by 2030, growing at a CAGR of 10.8% from 2021 to 2030.
PORTLAND, OREGON, UNITED STATES, May 26, 2023 /EINPresswire.com/ — The global veterinary oncology market was valued at $0.297 billion in 2020, and is estimated to reach $0.819 billion by 2030, growing at a CAGR of 10.8% from 2021 to 2030.
CAGR: 10.8%
โข Current Market Size: USD 297 Million
โข Forecast Growing Region: APAC
โข Largest Market: North America
โข Projection Time: 2021 โ 2030
โข Base Year: 202
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ซ๐- https://www.alliedmarketresearch.com/request-sample/7504
๐๐๐ฒ ๐๐๐ง๐๐๐ข๐ญ๐ฌ ๐
๐จ๐ซ ๐๐ญ๐๐ค๐๐ก๐จ๐ฅ๐๐๐ซ๐ฌ
The study provides an in-depth analysis of the veterinary oncology market, and the current trends & future estimations to elucidate imminent investment pockets.
It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing veterinary oncology market opportunities.
Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the veterinary oncology market.
๐๐ซ๐จ๐๐ฎ๐ซ๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐๐ฉ๐จ๐ซ๐ญ (257 ๐๐๐ ๐๐ฌ ๐๐๐ ๐ฐ๐ข๐ญ๐ก ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ก๐๐ซ๐ญ๐ฌ, ๐๐๐๐ฅ๐๐ฌ, ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ) @ https://www.alliedmarketresearch.com/veterinary-oncology-market/purchase-options
๐๐๐ฒ ๐
๐ข๐ง๐๐ข๐ง๐ ๐ฌ ๐๐ ๐๐ก๐ ๐๐ญ๐ฎ๐๐ฒ
By therapy, the chemotherapy segment was the highest contributor to the market in 2020.
On the basis of animal type, the canine segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
Depending on cancer, the lymphoma segment was the highest contributor to the market in 2020.
Region wise, North America garnered the largest revenue share in 2020, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
๐๐ฒ ๐๐ก๐๐ซ๐๐ฉ๐ฒ
Surgery
Radiology
Chemotherapy
Others
๐๐ฒ ๐๐ง๐ข๐ฆ๐๐ฅ ๐๐ฒ๐ฉ๐
Canine
Surgery
Radiology
Chemotherapy
Others
Feline
Surgery
Radiology
Chemotherapy
Others
๐๐ฒ ๐๐๐ง๐๐๐ซ
Lymphoma
Mast Cell Cancer
Mammary & Squamous Cell Cancer
Others
๐๐๐ญ๐๐ซ๐ข๐ง๐๐ซ๐ฒ ๐๐ง๐๐จ๐ฅ๐จ๐ ๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
Accuray Incorporated
Boehringer Ingelheim International GmbH
Elanco
Karyopharm Therapeutics, Inc.
Morphogenesis, Inc.
Nippon Zenyaku Kogyo Co.
PetCure Oncology
Regeneus Ltd.
Varian Medical System, Inc.
Zoetis
๐๐จ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ฒ๐ข๐ง๐ – https://www.alliedmarketresearch.com/purchase-enquiry/7504
In 2020, North America held the largest share of the global veterinary oncology market, a position that is expected to persist throughout the forecast period. This dominance can be attributed to several factors, including the growing incidence of cancer in companion animals, the presence of key players involved in drug manufacturing and development for animals, a substantial population of dogs and cats, and government initiatives supporting pet oncology treatment in the region.
On the other hand, the Asia-Pacific region is poised to experience significant growth in the veterinary oncology market. This growth is primarily driven by an increase in the prevalence of cancer in dogs, a rising demand for pet adoption, and the presence of various veterinary foundations that focus on cancer treatment and care.
๐๐ญ๐ก๐๐ซ ๐๐จ๐ฉ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ โ
๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐ฎ๐ฉ๐ฉ๐จ๐ฌ๐ข๐ญ๐จ๐ซ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ – https://www.alliedmarketresearch.com/pharmaceutical-suppositories-market-A12350
๐๐๐ซ๐ญ๐ข๐ ๐จ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐๐๐ซ๐ค๐๐ญ – https://www.alliedmarketresearch.com/vertigo-treatment-market-A12485
๐๐จ๐ญ๐ฎ๐ฅ๐ข๐ง๐ฎ๐ฆ ๐๐จ๐ฑ๐ข๐ง ๐๐๐ซ๐ค๐๐ญ – https://www.alliedmarketresearch.com/botulinum-toxin-market-A11935
David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
